nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—NTRK2—malignant glioma	0.376	0.529	CbGaD
Amitriptyline—NTRK1—malignant glioma	0.232	0.327	CbGaD
Amitriptyline—CYP2B6—malignant glioma	0.102	0.143	CbGaD
Amitriptyline—CYP1A2—Carmustine—malignant glioma	0.017	0.569	CbGbCtD
Amitriptyline—CYP3A4—Temozolomide—malignant glioma	0.0129	0.43	CbGbCtD
Amitriptyline—HTR1D—meninx—malignant glioma	0.00582	0.0555	CbGeAlD
Amitriptyline—HTR1B—dura mater—malignant glioma	0.00553	0.0528	CbGeAlD
Amitriptyline—HTR1D—dura mater—malignant glioma	0.00535	0.0511	CbGeAlD
Amitriptyline—NTRK2—telencephalic ventricle—malignant glioma	0.00465	0.0444	CbGeAlD
Amitriptyline—HTR2C—choroid plexus—malignant glioma	0.00451	0.043	CbGeAlD
Amitriptyline—DRD3—telencephalic ventricle—malignant glioma	0.00237	0.0227	CbGeAlD
Amitriptyline—HTR2A—choroid plexus—malignant glioma	0.00226	0.0216	CbGeAlD
Amitriptyline—ORM1—vertebral column—malignant glioma	0.00177	0.0169	CbGeAlD
Amitriptyline—Tongue discolouration—Temozolomide—malignant glioma	0.00154	0.044	CcSEcCtD
Amitriptyline—OPRM1—telencephalic ventricle—malignant glioma	0.00151	0.0144	CbGeAlD
Amitriptyline—HTR1B—telencephalic ventricle—malignant glioma	0.00138	0.0131	CbGeAlD
Amitriptyline—HTR1D—telencephalic ventricle—malignant glioma	0.00133	0.0127	CbGeAlD
Amitriptyline—HTR2C—telencephalic ventricle—malignant glioma	0.00132	0.0126	CbGeAlD
Amitriptyline—HTR7—pons—malignant glioma	0.00129	0.0123	CbGeAlD
Amitriptyline—Cerebration impaired—Temozolomide—malignant glioma	0.00126	0.0362	CcSEcCtD
Amitriptyline—NTRK2—brainstem—malignant glioma	0.00126	0.012	CbGeAlD
Amitriptyline—NTRK2—retina—malignant glioma	0.00122	0.0116	CbGeAlD
Amitriptyline—HTR2A—cerebellar cortex—malignant glioma	0.00114	0.0109	CbGeAlD
Amitriptyline—NTRK2—telencephalon—malignant glioma	0.00112	0.0107	CbGeAlD
Amitriptyline—HTR1A—telencephalic ventricle—malignant glioma	0.00111	0.0106	CbGeAlD
Amitriptyline—HTR7—telencephalic ventricle—malignant glioma	0.00106	0.0101	CbGeAlD
Amitriptyline—NTRK1—midbrain—malignant glioma	0.00105	0.01	CbGeAlD
Amitriptyline—DRD2—telencephalic ventricle—malignant glioma	0.001	0.00959	CbGeAlD
Amitriptyline—Extrapyramidal disorder—Temozolomide—malignant glioma	0.000987	0.0283	CcSEcCtD
Amitriptyline—KCNQ2—brainstem—malignant glioma	0.000878	0.00839	CbGeAlD
Amitriptyline—NTRK2—medulla oblongata—malignant glioma	0.000878	0.00838	CbGeAlD
Amitriptyline—Disturbance in attention—Temozolomide—malignant glioma	0.000858	0.0246	CcSEcCtD
Amitriptyline—KCNQ3—telencephalon—malignant glioma	0.000847	0.00809	CbGeAlD
Amitriptyline—KCND2—brainstem—malignant glioma	0.000832	0.00794	CbGeAlD
Amitriptyline—HTR2A—pons—malignant glioma	0.000805	0.00768	CbGeAlD
Amitriptyline—NTRK2—midbrain—malignant glioma	0.000803	0.00766	CbGeAlD
Amitriptyline—HTR2A—vertebral column—malignant glioma	0.000799	0.00763	CbGeAlD
Amitriptyline—Coordination abnormal—Carmustine—malignant glioma	0.000784	0.0224	CcSEcCtD
Amitriptyline—NTRK2—spinal cord—malignant glioma	0.000783	0.00748	CbGeAlD
Amitriptyline—KCNQ2—telencephalon—malignant glioma	0.00078	0.00744	CbGeAlD
Amitriptyline—Coordination abnormal—Temozolomide—malignant glioma	0.000757	0.0217	CcSEcCtD
Amitriptyline—KCND2—telencephalon—malignant glioma	0.000738	0.00705	CbGeAlD
Amitriptyline—KCNA1—brainstem—malignant glioma	0.000729	0.00696	CbGeAlD
Amitriptyline—KCND3—brainstem—malignant glioma	0.000725	0.00692	CbGeAlD
Amitriptyline—KCNA1—retina—malignant glioma	0.000703	0.00671	CbGeAlD
Amitriptyline—Coma—Carmustine—malignant glioma	0.000703	0.0201	CcSEcCtD
Amitriptyline—Gynaecomastia—Carmustine—malignant glioma	0.000688	0.0197	CcSEcCtD
Amitriptyline—HTR1B—blood vessel—malignant glioma	0.000682	0.00651	CbGeAlD
Amitriptyline—Mental disability—Carmustine—malignant glioma	0.000668	0.0191	CcSEcCtD
Amitriptyline—KCNQ3—medulla oblongata—malignant glioma	0.000666	0.00635	CbGeAlD
Amitriptyline—HTR2A—telencephalic ventricle—malignant glioma	0.000662	0.00632	CbGeAlD
Amitriptyline—HTR1D—blood vessel—malignant glioma	0.00066	0.0063	CbGeAlD
Amitriptyline—KCNA1—telencephalon—malignant glioma	0.000647	0.00618	CbGeAlD
Amitriptyline—Mental disability—Temozolomide—malignant glioma	0.000645	0.0185	CcSEcCtD
Amitriptyline—KCND3—telencephalon—malignant glioma	0.000644	0.00614	CbGeAlD
Amitriptyline—NTRK2—central nervous system—malignant glioma	0.000635	0.00606	CbGeAlD
Amitriptyline—NTRK2—cerebellum—malignant glioma	0.000621	0.00593	CbGeAlD
Amitriptyline—KCNQ3—midbrain—malignant glioma	0.000608	0.00581	CbGeAlD
Amitriptyline—Vascular purpura—Temozolomide—malignant glioma	0.000603	0.0173	CcSEcCtD
Amitriptyline—Hepatic failure—Temozolomide—malignant glioma	0.000601	0.0172	CcSEcCtD
Amitriptyline—KCND2—medulla oblongata—malignant glioma	0.00058	0.00554	CbGeAlD
Amitriptyline—HTR2A—pineal body—malignant glioma	0.000575	0.00549	CbGeAlD
Amitriptyline—HTR7—endothelium—malignant glioma	0.00057	0.00544	CbGeAlD
Amitriptyline—Purpura—Temozolomide—malignant glioma	0.00056	0.016	CcSEcCtD
Amitriptyline—HTR6—telencephalon—malignant glioma	0.000549	0.00524	CbGeAlD
Amitriptyline—KCND2—midbrain—malignant glioma	0.00053	0.00506	CbGeAlD
Amitriptyline—OPRD1—telencephalon—malignant glioma	0.00053	0.00506	CbGeAlD
Amitriptyline—HTR7—blood vessel—malignant glioma	0.000526	0.00502	CbGeAlD
Amitriptyline—Ataxia—Carmustine—malignant glioma	0.000525	0.015	CcSEcCtD
Amitriptyline—KCND2—spinal cord—malignant glioma	0.000517	0.00494	CbGeAlD
Amitriptyline—Ataxia—Temozolomide—malignant glioma	0.000508	0.0145	CcSEcCtD
Amitriptyline—NTRK2—brain—malignant glioma	0.000504	0.00481	CbGeAlD
Amitriptyline—KCNQ3—central nervous system—malignant glioma	0.000481	0.0046	CbGeAlD
Amitriptyline—KCNQ3—cerebellum—malignant glioma	0.000471	0.00449	CbGeAlD
Amitriptyline—KCNA1—midbrain—malignant glioma	0.000465	0.00444	CbGeAlD
Amitriptyline—KCND3—midbrain—malignant glioma	0.000462	0.00441	CbGeAlD
Amitriptyline—Pancytopenia—Carmustine—malignant glioma	0.000458	0.0131	CcSEcCtD
Amitriptyline—Sweating increased—Temozolomide—malignant glioma	0.000454	0.013	CcSEcCtD
Amitriptyline—KCNA1—spinal cord—malignant glioma	0.000453	0.00433	CbGeAlD
Amitriptyline—KCNQ2—central nervous system—malignant glioma	0.000443	0.00423	CbGeAlD
Amitriptyline—Pancytopenia—Temozolomide—malignant glioma	0.000443	0.0127	CcSEcCtD
Amitriptyline—KCNQ2—cerebellum—malignant glioma	0.000433	0.00413	CbGeAlD
Amitriptyline—Pollakiuria—Temozolomide—malignant glioma	0.000431	0.0123	CcSEcCtD
Amitriptyline—Erectile dysfunction—Temozolomide—malignant glioma	0.00043	0.0123	CcSEcCtD
Amitriptyline—ADRA1D—telencephalon—malignant glioma	0.000428	0.00409	CbGeAlD
Amitriptyline—Weight increased—Temozolomide—malignant glioma	0.000425	0.0121	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Carmustine—malignant glioma	0.000422	0.0121	CcSEcCtD
Amitriptyline—KCND2—central nervous system—malignant glioma	0.00042	0.00401	CbGeAlD
Amitriptyline—Stomatitis—Carmustine—malignant glioma	0.00042	0.012	CcSEcCtD
Amitriptyline—KCND2—cerebellum—malignant glioma	0.00041	0.00392	CbGeAlD
Amitriptyline—Neuropathy peripheral—Temozolomide—malignant glioma	0.000408	0.0117	CcSEcCtD
Amitriptyline—OPRM1—brainstem—malignant glioma	0.000407	0.00389	CbGeAlD
Amitriptyline—Stomatitis—Temozolomide—malignant glioma	0.000405	0.0116	CcSEcCtD
Amitriptyline—Hallucination—Carmustine—malignant glioma	0.000384	0.011	CcSEcCtD
Amitriptyline—Hypoaesthesia—Carmustine—malignant glioma	0.000384	0.011	CcSEcCtD
Amitriptyline—KCNQ3—brain—malignant glioma	0.000382	0.00365	CbGeAlD
Amitriptyline—Hepatitis—Temozolomide—malignant glioma	0.000373	0.0107	CcSEcCtD
Amitriptyline—HTR1B—brainstem—malignant glioma	0.000373	0.00356	CbGeAlD
Amitriptyline—Hypoaesthesia—Temozolomide—malignant glioma	0.000372	0.0106	CcSEcCtD
Amitriptyline—Hallucination—Temozolomide—malignant glioma	0.000372	0.0106	CcSEcCtD
Amitriptyline—KCNA1—central nervous system—malignant glioma	0.000368	0.00351	CbGeAlD
Amitriptyline—KCND3—central nervous system—malignant glioma	0.000366	0.00349	CbGeAlD
Amitriptyline—OPRM1—telencephalon—malignant glioma	0.000361	0.00345	CbGeAlD
Amitriptyline—HTR1D—brainstem—malignant glioma	0.000361	0.00344	CbGeAlD
Amitriptyline—KCNA1—cerebellum—malignant glioma	0.000359	0.00343	CbGeAlD
Amitriptyline—KCND3—cerebellum—malignant glioma	0.000358	0.00341	CbGeAlD
Amitriptyline—HTR2C—brainstem—malignant glioma	0.000357	0.00341	CbGeAlD
Amitriptyline—HTR2A—endothelium—malignant glioma	0.000356	0.00339	CbGeAlD
Amitriptyline—Epinastine—CYP2B6—malignant glioma	0.000355	0.12	CrCbGaD
Amitriptyline—KCNQ2—brain—malignant glioma	0.000352	0.00336	CbGeAlD
Amitriptyline—CHRM4—central nervous system—malignant glioma	0.000349	0.00333	CbGeAlD
Amitriptyline—Tinnitus—Temozolomide—malignant glioma	0.000348	0.00996	CcSEcCtD
Amitriptyline—Arrhythmia—Carmustine—malignant glioma	0.000345	0.00988	CcSEcCtD
Amitriptyline—Alopecia—Carmustine—malignant glioma	0.000341	0.00977	CcSEcCtD
Amitriptyline—SLC6A4—brainstem—malignant glioma	0.000339	0.00323	CbGeAlD
Amitriptyline—KCND2—brain—malignant glioma	0.000333	0.00318	CbGeAlD
Amitriptyline—HTR1B—telencephalon—malignant glioma	0.000331	0.00316	CbGeAlD
Amitriptyline—Alopecia—Temozolomide—malignant glioma	0.00033	0.00944	CcSEcCtD
Amitriptyline—CHRM2—telencephalon—malignant glioma	0.000329	0.00314	CbGeAlD
Amitriptyline—HTR2A—blood vessel—malignant glioma	0.000328	0.00313	CbGeAlD
Amitriptyline—DRD3—central nervous system—malignant glioma	0.000324	0.00309	CbGeAlD
Amitriptyline—HTR1D—telencephalon—malignant glioma	0.00032	0.00306	CbGeAlD
Amitriptyline—Dysgeusia—Temozolomide—malignant glioma	0.000318	0.00911	CcSEcCtD
Amitriptyline—HTR2C—telencephalon—malignant glioma	0.000317	0.00303	CbGeAlD
Amitriptyline—Vision blurred—Carmustine—malignant glioma	0.000317	0.00907	CcSEcCtD
Amitriptyline—Tremor—Carmustine—malignant glioma	0.000315	0.00902	CcSEcCtD
Amitriptyline—HTR6—central nervous system—malignant glioma	0.000312	0.00298	CbGeAlD
Amitriptyline—Agitation—Carmustine—malignant glioma	0.000309	0.00884	CcSEcCtD
Amitriptyline—Vision blurred—Temozolomide—malignant glioma	0.000306	0.00877	CcSEcCtD
Amitriptyline—Tremor—Temozolomide—malignant glioma	0.000305	0.00871	CcSEcCtD
Amitriptyline—Ill-defined disorder—Temozolomide—malignant glioma	0.000302	0.00863	CcSEcCtD
Amitriptyline—OPRD1—central nervous system—malignant glioma	0.000301	0.00288	CbGeAlD
Amitriptyline—Leukopenia—Carmustine—malignant glioma	0.000301	0.00862	CcSEcCtD
Amitriptyline—HTR1A—brainstem—malignant glioma	0.000301	0.00287	CbGeAlD
Amitriptyline—SLC6A4—telencephalon—malignant glioma	0.000301	0.00287	CbGeAlD
Amitriptyline—CHRM1—telencephalon—malignant glioma	0.000299	0.00286	CbGeAlD
Amitriptyline—Agitation—Temozolomide—malignant glioma	0.000299	0.00855	CcSEcCtD
Amitriptyline—SIGMAR1—telencephalon—malignant glioma	0.000299	0.00285	CbGeAlD
Amitriptyline—SLC6A2—brainstem—malignant glioma	0.000298	0.00285	CbGeAlD
Amitriptyline—Malaise—Temozolomide—malignant glioma	0.000293	0.00839	CcSEcCtD
Amitriptyline—KCNA1—brain—malignant glioma	0.000292	0.00279	CbGeAlD
Amitriptyline—Convulsion—Carmustine—malignant glioma	0.000291	0.00834	CcSEcCtD
Amitriptyline—Leukopenia—Temozolomide—malignant glioma	0.000291	0.00833	CcSEcCtD
Amitriptyline—KCND3—brain—malignant glioma	0.00029	0.00277	CbGeAlD
Amitriptyline—Hypertension—Carmustine—malignant glioma	0.00029	0.00831	CcSEcCtD
Amitriptyline—OPRK1—central nervous system—malignant glioma	0.000289	0.00276	CbGeAlD
Amitriptyline—HTR7—brainstem—malignant glioma	0.000287	0.00274	CbGeAlD
Amitriptyline—Palpitations—Temozolomide—malignant glioma	0.000287	0.00822	CcSEcCtD
Amitriptyline—Anxiety—Carmustine—malignant glioma	0.000285	0.00817	CcSEcCtD
Amitriptyline—HRH2—central nervous system—malignant glioma	0.000285	0.00272	CbGeAlD
Amitriptyline—OPRK1—cerebellum—malignant glioma	0.000282	0.00269	CbGeAlD
Amitriptyline—Convulsion—Temozolomide—malignant glioma	0.000282	0.00806	CcSEcCtD
Amitriptyline—Hypertension—Temozolomide—malignant glioma	0.000281	0.00803	CcSEcCtD
Amitriptyline—ADRA1A—brainstem—malignant glioma	0.000277	0.00265	CbGeAlD
Amitriptyline—Confusional state—Carmustine—malignant glioma	0.000277	0.00792	CcSEcCtD
Amitriptyline—CHRM4—brain—malignant glioma	0.000277	0.00264	CbGeAlD
Amitriptyline—Anxiety—Temozolomide—malignant glioma	0.000276	0.00789	CcSEcCtD
Amitriptyline—Oedema—Carmustine—malignant glioma	0.000275	0.00786	CcSEcCtD
Amitriptyline—Discomfort—Temozolomide—malignant glioma	0.000273	0.00782	CcSEcCtD
Amitriptyline—CHRM5—central nervous system—malignant glioma	0.000272	0.0026	CbGeAlD
Amitriptyline—DRD2—brainstem—malignant glioma	0.000272	0.00259	CbGeAlD
Amitriptyline—Dry mouth—Temozolomide—malignant glioma	0.000271	0.00774	CcSEcCtD
Amitriptyline—Thrombocytopenia—Carmustine—malignant glioma	0.000269	0.00769	CcSEcCtD
Amitriptyline—CHRM3—telencephalon—malignant glioma	0.000268	0.00256	CbGeAlD
Amitriptyline—Tachycardia—Carmustine—malignant glioma	0.000268	0.00767	CcSEcCtD
Amitriptyline—Confusional state—Temozolomide—malignant glioma	0.000267	0.00765	CcSEcCtD
Amitriptyline—HTR1A—telencephalon—malignant glioma	0.000267	0.00255	CbGeAlD
Amitriptyline—Oedema—Temozolomide—malignant glioma	0.000265	0.00759	CcSEcCtD
Amitriptyline—SLC6A2—telencephalon—malignant glioma	0.000265	0.00253	CbGeAlD
Amitriptyline—DRD2—retina—malignant glioma	0.000262	0.0025	CbGeAlD
Amitriptyline—Anorexia—Carmustine—malignant glioma	0.000262	0.00749	CcSEcCtD
Amitriptyline—Thrombocytopenia—Temozolomide—malignant glioma	0.00026	0.00743	CcSEcCtD
Amitriptyline—OPRM1—midbrain—malignant glioma	0.00026	0.00248	CbGeAlD
Amitriptyline—DRD3—brain—malignant glioma	0.000257	0.00246	CbGeAlD
Amitriptyline—Hypotension—Carmustine—malignant glioma	0.000257	0.00734	CcSEcCtD
Amitriptyline—Hyperhidrosis—Temozolomide—malignant glioma	0.000256	0.00734	CcSEcCtD
Amitriptyline—HTR7—telencephalon—malignant glioma	0.000255	0.00243	CbGeAlD
Amitriptyline—OPRM1—spinal cord—malignant glioma	0.000253	0.00242	CbGeAlD
Amitriptyline—Anorexia—Temozolomide—malignant glioma	0.000253	0.00724	CcSEcCtD
Amitriptyline—HTR2C—medulla oblongata—malignant glioma	0.000249	0.00238	CbGeAlD
Amitriptyline—ADRA1B—central nervous system—malignant glioma	0.000249	0.00238	CbGeAlD
Amitriptyline—Insomnia—Carmustine—malignant glioma	0.000248	0.0071	CcSEcCtD
Amitriptyline—HTR6—brain—malignant glioma	0.000248	0.00236	CbGeAlD
Amitriptyline—ORM1—spinal cord—malignant glioma	0.000247	0.00236	CbGeAlD
Amitriptyline—Paraesthesia—Carmustine—malignant glioma	0.000246	0.00705	CcSEcCtD
Amitriptyline—ADRA1A—telencephalon—malignant glioma	0.000246	0.00235	CbGeAlD
Amitriptyline—Somnolence—Carmustine—malignant glioma	0.000244	0.00698	CcSEcCtD
Amitriptyline—ADRA1D—central nervous system—malignant glioma	0.000243	0.00232	CbGeAlD
Amitriptyline—DRD2—telencephalon—malignant glioma	0.000241	0.0023	CbGeAlD
Amitriptyline—Insomnia—Temozolomide—malignant glioma	0.00024	0.00687	CcSEcCtD
Amitriptyline—OPRD1—brain—malignant glioma	0.000239	0.00228	CbGeAlD
Amitriptyline—Decreased appetite—Carmustine—malignant glioma	0.000239	0.00683	CcSEcCtD
Amitriptyline—Paraesthesia—Temozolomide—malignant glioma	0.000238	0.00682	CcSEcCtD
Amitriptyline—HTR1B—midbrain—malignant glioma	0.000238	0.00227	CbGeAlD
Amitriptyline—Somnolence—Temozolomide—malignant glioma	0.000236	0.00675	CcSEcCtD
Amitriptyline—Constipation—Carmustine—malignant glioma	0.000235	0.00672	CcSEcCtD
Amitriptyline—SIGMAR1—medulla oblongata—malignant glioma	0.000235	0.00224	CbGeAlD
Amitriptyline—Dyspepsia—Temozolomide—malignant glioma	0.000234	0.00668	CcSEcCtD
Amitriptyline—HTR1B—spinal cord—malignant glioma	0.000232	0.00221	CbGeAlD
Amitriptyline—Decreased appetite—Temozolomide—malignant glioma	0.000231	0.0066	CcSEcCtD
Amitriptyline—HTR1D—midbrain—malignant glioma	0.00023	0.00219	CbGeAlD
Amitriptyline—OPRK1—brain—malignant glioma	0.000229	0.00219	CbGeAlD
Amitriptyline—Fatigue—Temozolomide—malignant glioma	0.000229	0.00654	CcSEcCtD
Amitriptyline—Diphenhydramine—CYP2C18—malignant glioma	0.000228	0.0773	CrCbGaD
Amitriptyline—HTR2C—midbrain—malignant glioma	0.000228	0.00217	CbGeAlD
Amitriptyline—Constipation—Temozolomide—malignant glioma	0.000227	0.00649	CcSEcCtD
Amitriptyline—HRH2—brain—malignant glioma	0.000226	0.00216	CbGeAlD
Amitriptyline—Feeling abnormal—Carmustine—malignant glioma	0.000226	0.00647	CcSEcCtD
Amitriptyline—Clomipramine—GSTP1—malignant glioma	0.000223	0.0755	CrCbGaD
Amitriptyline—HTR2C—spinal cord—malignant glioma	0.000222	0.00212	CbGeAlD
Amitriptyline—Feeling abnormal—Temozolomide—malignant glioma	0.000219	0.00626	CcSEcCtD
Amitriptyline—Body temperature increased—Carmustine—malignant glioma	0.000217	0.00621	CcSEcCtD
Amitriptyline—CHRM5—brain—malignant glioma	0.000216	0.00206	CbGeAlD
Amitriptyline—SLC6A4—midbrain—malignant glioma	0.000216	0.00206	CbGeAlD
Amitriptyline—ABCB1—blood vessel—malignant glioma	0.000215	0.00205	CbGeAlD
Amitriptyline—SIGMAR1—midbrain—malignant glioma	0.000214	0.00205	CbGeAlD
Amitriptyline—Urticaria—Temozolomide—malignant glioma	0.000211	0.00603	CcSEcCtD
Amitriptyline—SLC6A4—spinal cord—malignant glioma	0.000211	0.00201	CbGeAlD
Amitriptyline—Body temperature increased—Temozolomide—malignant glioma	0.00021	0.006	CcSEcCtD
Amitriptyline—SIGMAR1—spinal cord—malignant glioma	0.000209	0.002	CbGeAlD
Amitriptyline—SLC6A2—medulla oblongata—malignant glioma	0.000208	0.00198	CbGeAlD
Amitriptyline—OPRM1—central nervous system—malignant glioma	0.000205	0.00196	CbGeAlD
Amitriptyline—Mianserin—CYP2B6—malignant glioma	0.000205	0.0694	CrCbGaD
Amitriptyline—Desipramine—CYP2C18—malignant glioma	0.000203	0.0688	CrCbGaD
Amitriptyline—ORM1—central nervous system—malignant glioma	0.000201	0.00191	CbGeAlD
Amitriptyline—HTR7—medulla oblongata—malignant glioma	0.0002	0.00191	CbGeAlD
Amitriptyline—ADRA1B—brain—malignant glioma	0.000198	0.00189	CbGeAlD
Amitriptyline—Asthenia—Carmustine—malignant glioma	0.000197	0.00564	CcSEcCtD
Amitriptyline—HTR2A—embryo—malignant glioma	0.000196	0.00187	CbGeAlD
Amitriptyline—ADRA1D—brain—malignant glioma	0.000193	0.00185	CbGeAlD
Amitriptyline—HTR1A—midbrain—malignant glioma	0.000192	0.00183	CbGeAlD
Amitriptyline—HRH1—telencephalon—malignant glioma	0.00019	0.00182	CbGeAlD
Amitriptyline—Asthenia—Temozolomide—malignant glioma	0.00019	0.00545	CcSEcCtD
Amitriptyline—HTR1B—central nervous system—malignant glioma	0.000188	0.00179	CbGeAlD
Amitriptyline—Diarrhoea—Carmustine—malignant glioma	0.000188	0.00537	CcSEcCtD
Amitriptyline—Pruritus—Temozolomide—malignant glioma	0.000188	0.00537	CcSEcCtD
Amitriptyline—ADRA2A—telencephalon—malignant glioma	0.000187	0.00179	CbGeAlD
Amitriptyline—HTR1A—spinal cord—malignant glioma	0.000187	0.00178	CbGeAlD
Amitriptyline—CHRM2—central nervous system—malignant glioma	0.000187	0.00178	CbGeAlD
Amitriptyline—HTR7—midbrain—malignant glioma	0.000183	0.00175	CbGeAlD
Amitriptyline—CYP2E1—telencephalon—malignant glioma	0.000183	0.00175	CbGeAlD
Amitriptyline—HTR1D—central nervous system—malignant glioma	0.000182	0.00174	CbGeAlD
Amitriptyline—Dizziness—Carmustine—malignant glioma	0.000182	0.00519	CcSEcCtD
Amitriptyline—Diarrhoea—Temozolomide—malignant glioma	0.000182	0.00519	CcSEcCtD
Amitriptyline—HTR2C—central nervous system—malignant glioma	0.00018	0.00172	CbGeAlD
Amitriptyline—HTR2A—brainstem—malignant glioma	0.000179	0.00171	CbGeAlD
Amitriptyline—HTR7—spinal cord—malignant glioma	0.000179	0.00171	CbGeAlD
Amitriptyline—Dizziness—Temozolomide—malignant glioma	0.000175	0.00502	CcSEcCtD
Amitriptyline—Mianserin—SLC6A3—malignant glioma	0.000175	0.0592	CrCbGaD
Amitriptyline—Vomiting—Carmustine—malignant glioma	0.000175	0.00499	CcSEcCtD
Amitriptyline—DRD2—midbrain—malignant glioma	0.000173	0.00165	CbGeAlD
Amitriptyline—Rash—Carmustine—malignant glioma	0.000173	0.00495	CcSEcCtD
Amitriptyline—Dermatitis—Carmustine—malignant glioma	0.000173	0.00495	CcSEcCtD
Amitriptyline—HTR2A—retina—malignant glioma	0.000173	0.00165	CbGeAlD
Amitriptyline—Imipramine—CYP2C18—malignant glioma	0.000173	0.0584	CrCbGaD
Amitriptyline—Headache—Carmustine—malignant glioma	0.000172	0.00492	CcSEcCtD
Amitriptyline—SLC6A4—central nervous system—malignant glioma	0.000171	0.00163	CbGeAlD
Amitriptyline—CHRM1—central nervous system—malignant glioma	0.00017	0.00162	CbGeAlD
Amitriptyline—Diphenhydramine—CYP2B6—malignant glioma	0.00017	0.0574	CrCbGaD
Amitriptyline—Vomiting—Temozolomide—malignant glioma	0.000169	0.00483	CcSEcCtD
Amitriptyline—Rash—Temozolomide—malignant glioma	0.000167	0.00479	CcSEcCtD
Amitriptyline—Dermatitis—Temozolomide—malignant glioma	0.000167	0.00478	CcSEcCtD
Amitriptyline—Promethazine—CYP2B6—malignant glioma	0.000166	0.0563	CrCbGaD
Amitriptyline—Headache—Temozolomide—malignant glioma	0.000166	0.00476	CcSEcCtD
Amitriptyline—SIGMAR1—cerebellum—malignant glioma	0.000166	0.00158	CbGeAlD
Amitriptyline—CYP2D6—brainstem—malignant glioma	0.000163	0.00156	CbGeAlD
Amitriptyline—OPRM1—brain—malignant glioma	0.000163	0.00156	CbGeAlD
Amitriptyline—Nausea—Carmustine—malignant glioma	0.000163	0.00467	CcSEcCtD
Amitriptyline—Orphenadrine—CYP2B6—malignant glioma	0.00016	0.0543	CrCbGaD
Amitriptyline—HTR2A—telencephalon—malignant glioma	0.000159	0.00152	CbGeAlD
Amitriptyline—Nausea—Temozolomide—malignant glioma	0.000158	0.00451	CcSEcCtD
Amitriptyline—CHRM3—central nervous system—malignant glioma	0.000152	0.00145	CbGeAlD
Amitriptyline—HTR1A—central nervous system—malignant glioma	0.000152	0.00145	CbGeAlD
Amitriptyline—Desipramine—CYP2B6—malignant glioma	0.000151	0.0511	CrCbGaD
Amitriptyline—SLC6A2—central nervous system—malignant glioma	0.00015	0.00144	CbGeAlD
Amitriptyline—HTR1B—brain—malignant glioma	0.000149	0.00142	CbGeAlD
Amitriptyline—CHRM2—brain—malignant glioma	0.000148	0.00142	CbGeAlD
Amitriptyline—HTR1A—cerebellum—malignant glioma	0.000148	0.00142	CbGeAlD
Amitriptyline—Trimipramine—SLC6A3—malignant glioma	0.000147	0.0498	CrCbGaD
Amitriptyline—ADRA2A—medulla oblongata—malignant glioma	0.000147	0.0014	CbGeAlD
Amitriptyline—HTR7—central nervous system—malignant glioma	0.000145	0.00138	CbGeAlD
Amitriptyline—CYP2D6—telencephalon—malignant glioma	0.000145	0.00138	CbGeAlD
Amitriptyline—HTR1D—brain—malignant glioma	0.000144	0.00138	CbGeAlD
Amitriptyline—CYP2E1—medulla oblongata—malignant glioma	0.000144	0.00137	CbGeAlD
Amitriptyline—HTR2C—brain—malignant glioma	0.000143	0.00137	CbGeAlD
Amitriptyline—HTR7—cerebellum—malignant glioma	0.000142	0.00135	CbGeAlD
Amitriptyline—ADRA1A—central nervous system—malignant glioma	0.00014	0.00133	CbGeAlD
Amitriptyline—ALB—brain—malignant glioma	0.00014	0.00133	CbGeAlD
Amitriptyline—DRD2—central nervous system—malignant glioma	0.000137	0.00131	CbGeAlD
Amitriptyline—ADRA1A—cerebellum—malignant glioma	0.000137	0.0013	CbGeAlD
Amitriptyline—SLC6A4—brain—malignant glioma	0.000136	0.00129	CbGeAlD
Amitriptyline—CHRM1—brain—malignant glioma	0.000135	0.00129	CbGeAlD
Amitriptyline—SIGMAR1—brain—malignant glioma	0.000135	0.00129	CbGeAlD
Amitriptyline—ADRA2A—midbrain—malignant glioma	0.000134	0.00128	CbGeAlD
Amitriptyline—DRD2—cerebellum—malignant glioma	0.000134	0.00128	CbGeAlD
Amitriptyline—ADRA2A—spinal cord—malignant glioma	0.000131	0.00125	CbGeAlD
Amitriptyline—Desipramine—SLC6A3—malignant glioma	0.000129	0.0435	CrCbGaD
Amitriptyline—CYP2E1—spinal cord—malignant glioma	0.000128	0.00122	CbGeAlD
Amitriptyline—ABCB1—embryo—malignant glioma	0.000128	0.00122	CbGeAlD
Amitriptyline—Imipramine—CYP2B6—malignant glioma	0.000128	0.0433	CrCbGaD
Amitriptyline—HTR2A—medulla oblongata—malignant glioma	0.000125	0.00119	CbGeAlD
Amitriptyline—CHRM3—brain—malignant glioma	0.000121	0.00115	CbGeAlD
Amitriptyline—Nortriptyline—PTGS1—malignant glioma	0.000121	0.0408	CrCbGaD
Amitriptyline—HTR1A—brain—malignant glioma	0.00012	0.00115	CbGeAlD
Amitriptyline—SLC6A2—brain—malignant glioma	0.000119	0.00114	CbGeAlD
Amitriptyline—HTR7—brain—malignant glioma	0.000115	0.0011	CbGeAlD
Amitriptyline—HTR2A—midbrain—malignant glioma	0.000114	0.00109	CbGeAlD
Amitriptyline—ABCB1—retina—malignant glioma	0.000113	0.00108	CbGeAlD
Amitriptyline—Diphenhydramine—PTGS1—malignant glioma	0.000112	0.0378	CrCbGaD
Amitriptyline—HTR2A—spinal cord—malignant glioma	0.000111	0.00106	CbGeAlD
Amitriptyline—ADRA1A—brain—malignant glioma	0.000111	0.00106	CbGeAlD
Amitriptyline—CYP2B6—central nervous system—malignant glioma	0.000111	0.00106	CbGeAlD
Amitriptyline—Imipramine—SLC6A3—malignant glioma	0.000109	0.0369	CrCbGaD
Amitriptyline—DRD2—brain—malignant glioma	0.000109	0.00104	CbGeAlD
Amitriptyline—HRH1—central nervous system—malignant glioma	0.000108	0.00103	CbGeAlD
Amitriptyline—ADRA2A—central nervous system—malignant glioma	0.000106	0.00101	CbGeAlD
Amitriptyline—ABCB1—telencephalon—malignant glioma	0.000104	0.000995	CbGeAlD
Amitriptyline—CYP2E1—central nervous system—malignant glioma	0.000104	0.000993	CbGeAlD
Amitriptyline—ADRA2A—cerebellum—malignant glioma	0.000104	0.000992	CbGeAlD
Amitriptyline—CYP2E1—cerebellum—malignant glioma	0.000102	0.00097	CbGeAlD
Amitriptyline—CYP2C8—brain—malignant glioma	9.81e-05	0.000936	CbGeAlD
Amitriptyline—HTR2A—central nervous system—malignant glioma	9.04e-05	0.000863	CbGeAlD
Amitriptyline—HTR2A—cerebellum—malignant glioma	8.84e-05	0.000843	CbGeAlD
Amitriptyline—CYP2B6—brain—malignant glioma	8.8e-05	0.00084	CbGeAlD
Amitriptyline—HRH1—brain—malignant glioma	8.59e-05	0.00082	CbGeAlD
Amitriptyline—ADRA2A—brain—malignant glioma	8.44e-05	0.000806	CbGeAlD
Amitriptyline—CYP3A4—central nervous system—malignant glioma	8.37e-05	0.000799	CbGeAlD
Amitriptyline—CYP2E1—brain—malignant glioma	8.26e-05	0.000788	CbGeAlD
Amitriptyline—CYP2D6—central nervous system—malignant glioma	8.24e-05	0.000786	CbGeAlD
Amitriptyline—ABCB1—medulla oblongata—malignant glioma	8.19e-05	0.000782	CbGeAlD
Amitriptyline—CYP2D6—cerebellum—malignant glioma	8.05e-05	0.000768	CbGeAlD
Amitriptyline—ABCB1—midbrain—malignant glioma	7.49e-05	0.000715	CbGeAlD
Amitriptyline—ABCB1—spinal cord—malignant glioma	7.3e-05	0.000697	CbGeAlD
Amitriptyline—HTR2A—brain—malignant glioma	7.18e-05	0.000685	CbGeAlD
Amitriptyline—CYP2D6—brain—malignant glioma	6.54e-05	0.000624	CbGeAlD
Amitriptyline—ABCB1—central nervous system—malignant glioma	5.92e-05	0.000566	CbGeAlD
Amitriptyline—ABCB1—cerebellum—malignant glioma	5.79e-05	0.000553	CbGeAlD
Amitriptyline—ABCB1—brain—malignant glioma	4.7e-05	0.000449	CbGeAlD
Amitriptyline—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.84e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTEN—malignant glioma	1.84e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.84e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KRAS—malignant glioma	1.84e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—malignant glioma	1.83e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1.83e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CASP3—malignant glioma	1.83e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL2—malignant glioma	1.83e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—malignant glioma	1.83e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—malignant glioma	1.83e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1.83e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	1.82e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	1.82e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—AKT1—malignant glioma	1.81e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.81e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.81e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	1.81e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—malignant glioma	1.81e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	1.81e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—malignant glioma	1.8e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	1.8e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CASP3—malignant glioma	1.8e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL2—malignant glioma	1.8e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CASP3—malignant glioma	1.8e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.8e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL2—malignant glioma	1.79e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—malignant glioma	1.79e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CASP3—malignant glioma	1.79e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL2—malignant glioma	1.79e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CASP3—malignant glioma	1.79e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	1.79e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL2—malignant glioma	1.78e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	1.78e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.78e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.77e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CASP3—malignant glioma	1.77e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL2—malignant glioma	1.77e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—AKT1—malignant glioma	1.77e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1.76e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	1.76e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL2—malignant glioma	1.76e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—malignant glioma	1.76e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—malignant glioma	1.76e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.75e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PPARG—malignant glioma	1.75e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—STAT3—malignant glioma	1.74e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KRAS—malignant glioma	1.74e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTP1—malignant glioma	1.74e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PPARG—malignant glioma	1.73e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.73e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MMP9—malignant glioma	1.73e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTEN—malignant glioma	1.73e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KRAS—malignant glioma	1.73e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KRAS—malignant glioma	1.73e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PTEN—malignant glioma	1.72e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	1.71e-06	1.46e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—malignant glioma	1.7e-06	1.46e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MMP9—malignant glioma	1.7e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MMP9—malignant glioma	1.7e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MMP9—malignant glioma	1.69e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PTEN—malignant glioma	1.69e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTEN—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CD—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CAT—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PTEN—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTEN—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CAV1—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	1.69e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PTEN—malignant glioma	1.68e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CB—malignant glioma	1.68e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AKT1—malignant glioma	1.68e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PTEN—malignant glioma	1.68e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—malignant glioma	1.68e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—malignant glioma	1.67e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—STAT3—malignant glioma	1.67e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—malignant glioma	1.67e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—malignant glioma	1.67e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTEN—malignant glioma	1.66e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTEN—malignant glioma	1.66e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.65e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—malignant glioma	1.65e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—malignant glioma	1.65e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—malignant glioma	1.64e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.64e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—malignant glioma	1.64e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.64e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—malignant glioma	1.63e-06	1.39e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—malignant glioma	1.63e-06	1.39e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—malignant glioma	1.62e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—malignant glioma	1.62e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	1.62e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.61e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	1.6e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NCOR1—malignant glioma	1.6e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.59e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.59e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—malignant glioma	1.59e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	1.59e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—malignant glioma	1.58e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.58e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—malignant glioma	1.55e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—malignant glioma	1.55e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—malignant glioma	1.55e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.55e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—malignant glioma	1.55e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.54e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—malignant glioma	1.54e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.54e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—malignant glioma	1.53e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—malignant glioma	1.53e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—malignant glioma	1.53e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—malignant glioma	1.53e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—malignant glioma	1.53e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—malignant glioma	1.52e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—malignant glioma	1.52e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—malignant glioma	1.52e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—malignant glioma	1.52e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—malignant glioma	1.51e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—malignant glioma	1.51e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—malignant glioma	1.51e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.51e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—malignant glioma	1.51e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.5e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.5e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—malignant glioma	1.5e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—malignant glioma	1.5e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	1.5e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—malignant glioma	1.5e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—malignant glioma	1.5e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—malignant glioma	1.49e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—malignant glioma	1.48e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—malignant glioma	1.48e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARG—malignant glioma	1.48e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CB—malignant glioma	1.47e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—malignant glioma	1.46e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—malignant glioma	1.46e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—malignant glioma	1.45e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—malignant glioma	1.44e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—malignant glioma	1.43e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—malignant glioma	1.43e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—malignant glioma	1.42e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—malignant glioma	1.41e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—malignant glioma	1.4e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—malignant glioma	1.4e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—malignant glioma	1.4e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—malignant glioma	1.39e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	1.39e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.39e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	1.38e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—malignant glioma	1.38e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—malignant glioma	1.38e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—malignant glioma	1.38e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—malignant glioma	1.38e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.38e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—malignant glioma	1.38e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.38e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	1.37e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—malignant glioma	1.37e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—malignant glioma	1.37e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—malignant glioma	1.36e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—malignant glioma	1.36e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—malignant glioma	1.35e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.35e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—malignant glioma	1.35e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—malignant glioma	1.34e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—malignant glioma	1.33e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—malignant glioma	1.32e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	1.32e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—malignant glioma	1.31e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—malignant glioma	1.3e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CAV1—malignant glioma	1.3e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.3e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.3e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—malignant glioma	1.3e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—malignant glioma	1.3e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—malignant glioma	1.3e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—malignant glioma	1.29e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—malignant glioma	1.29e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.28e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—malignant glioma	1.28e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—malignant glioma	1.27e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—malignant glioma	1.27e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.27e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.25e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—malignant glioma	1.22e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.21e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—malignant glioma	1.2e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.19e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.19e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.19e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.19e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—malignant glioma	1.19e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	1.19e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.18e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	1.18e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.18e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.18e-06	1e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—malignant glioma	1.17e-06	1e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.17e-06	1e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.17e-06	9.99e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—malignant glioma	1.17e-06	9.96e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—malignant glioma	1.16e-06	9.88e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—malignant glioma	1.16e-06	9.87e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—malignant glioma	1.15e-06	9.85e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—malignant glioma	1.15e-06	9.81e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—malignant glioma	1.15e-06	9.78e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARG—malignant glioma	1.14e-06	9.77e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—malignant glioma	1.13e-06	9.69e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.13e-06	9.66e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.13e-06	9.64e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.12e-06	9.6e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.09e-06	9.28e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.08e-06	9.18e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—malignant glioma	1.06e-06	9.07e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.05e-06	8.98e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.04e-06	8.9e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.03e-06	8.81e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—malignant glioma	1.03e-06	8.76e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—malignant glioma	1.02e-06	8.68e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—malignant glioma	9.95e-07	8.5e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—malignant glioma	9.91e-07	8.47e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—malignant glioma	9.75e-07	8.33e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—malignant glioma	9.75e-07	8.32e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—malignant glioma	9.73e-07	8.31e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—malignant glioma	9.73e-07	8.31e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—malignant glioma	9.7e-07	8.29e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—malignant glioma	9.67e-07	8.26e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—malignant glioma	9.58e-07	8.18e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—malignant glioma	9.55e-07	8.16e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—malignant glioma	9.2e-07	7.86e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.08e-07	7.76e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—malignant glioma	9e-07	7.68e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—malignant glioma	8.98e-07	7.67e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—malignant glioma	8.87e-07	7.58e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—malignant glioma	8.47e-07	7.23e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—malignant glioma	8.42e-07	7.2e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—malignant glioma	8.39e-07	7.17e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—malignant glioma	8.38e-07	7.15e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—malignant glioma	7.85e-07	6.7e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—malignant glioma	7.52e-07	6.42e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—malignant glioma	7.34e-07	6.27e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—malignant glioma	7.17e-07	6.13e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—malignant glioma	6.92e-07	5.91e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—malignant glioma	6.86e-07	5.86e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—malignant glioma	5.86e-07	5e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.53e-07	4.73e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—malignant glioma	4.52e-07	3.86e-06	CbGpPWpGaD
